• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Workshop: Access Options

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-06-01-2001
Volume 0
Issue 0

Hosbjor, Norway-Away from the media glare in South Africa, a three-day workshop sponsored by the World Health and World Trade organizations sought to improve access to life-saving medicines in developing countries. Also backed by the Norwegian Foreign Ministry and the Global Health Council, the workshop brought together 80 experts from 23 countries and highlighted the use of differential pricing as a means of improving access.

Articles in this issue
Industry Under Investigation
Covering the Bases
Emotion - The New Brand Integrator
For Love of the Game
Field of Dreams
Workshop: Access Options
Emotion - The New Brand Integrator
Rx-to-OTC: Unwanted Attention
Emotion - Biotech Renaissance Man
Biotech Renaissance Man
Relocation: Coming to America
Biotechnology: German Industry Beefs Up
Stocks: Catching the Market Blues
Gathering Light
Related Videos
Related Content
FDA Approves High Concentration, Citrate-Free Version of Cyltezo, Boehringer Ingelheim’s Humira Biosimilar for Chronic Inflammatory Diseases

FDA Approves High Concentration, Citrate-Free Version of Cyltezo, Boehringer Ingelheim’s Humira Biosimilar for Chronic Inflammatory Diseases

May 1st 2024
Article

New formulation of Cyltezo aims to complement the existing low-concentration formulation and offer more treatment options for various chronic inflammatory diseases.

A Decade in the Anti-Obesity Arena

A Decade in the Anti-Obesity Arena

April 30th 2024
Podcast

Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity medication, how expanded access can help with the world's obesity epidemic, when prices should come down, and much more.

Pharma Pulse 5/1/24: Walmart to Shut All Health Clinics in US, Food Allergies vs Food Intolerances & more

Pharma Pulse 5/1/24: Walmart to Shut All Health Clinics in US, Food Allergies vs Food Intolerances & more

May 1st 2024
Article

The latest news for pharma industry insiders.

The State of Mining Data Insights in the Life Sciences Industry – 2024

The State of Mining Data Insights in the Life Sciences Industry – 2024

April 30th 2024
Podcast

A Frost & Sullivan industry-wide survey reveals which insights most pharmaceutical companies have mastered and which are still painful or impossible to extract and details the complexity of the process, the confidence companies have in their findings, and more. Hear Web Sun, President and Co-founder of Komodo Health, share what's driving these challenges and how you can overcome them.

Site Logo

CMC Considerations for Complex Site Transfer Planning and Collaborating with Receiving Sites

May 1st 2024
Article
FDA Approves Abbott’s Dissolving Stent System for Chronic Limb-Threatening Ischemia in Arteries Below the Knee

FDA Approves Abbott’s Dissolving Stent System for Chronic Limb-Threatening Ischemia in Arteries Below the Knee

April 30th 2024
Article

Treatment marks the first dissolving stent approved in the United States for treating chronic limb-threatening ischemia in arteries below the knee.